Health Alert: FDA panel recommends against approving MDMA to treat PTSD. It’s unclear whether the agency will authorize the novel treatment.

Committee members said there is not enough evidence that use of the drug, also known as ecstasy, can be used safely and effectively. But the Food and Drug Administration sometimes sets aside recommendations of its advisory panels, so there's still a chance the agency will approve the first-of-its kind application for a psychedelic drug. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Sign up for alerts Health Alert June 4, 5:55 p.m. EDT FDA panel recommends against approving MDMA to treat PTSD. It's unclear whether the agency will authorize the novel treatment. Committee members said there is not enough evidence that use of the drug, also known as ecstasy, can be used safely and effectively. But the Food and Drug Administration sometimes sets aside recommendations of its advisory panels, so there's still a chance the agency will approve the first-of-its kind application for a psychedelic drug. Read more   Advertisement

Manage my email newsletters and alerts | Unsubscribe | Privacy Policy | Help You received this email because you signed up for news alerts or because it is included in your subscription. ©2024 The Washington Post | 1301 K St NW, Washington DC 20071